Notice of Registration - 2013
[Federal Register Volume 78, Number 54 (Wednesday, March 20, 2013)]
[Notices]
[Pages 17231-17232]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-06324]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration:
Noramco, Inc.
By Notice dated November 1, 2012, and published in the Federal
Register on November 9, 2012, 77 FR 67397, Noramco, Inc., 1440 Olympic
Drive, Athens, Georgia 30601, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the basic classes of controlled substances:
| Drug |
Schedule |
| Gamma Hydroxybutyric Acid (2010) |
I |
| Codeine-N-Oxide (9053) |
I |
| Dihydromorphine (9145) |
I |
| Morphine-N-oxide (9307) |
I |
| Amphetamine (1100) |
II |
| Methylphenidate (1724) |
II |
| Codeine (9050) |
II |
| Dihydrocodeine (9120) |
II |
| Oxycodone (9143) |
II |
| Hydromorphone (9150) |
II |
| Hydrocodone (9193) |
II |
| Morphine (9300) |
II |
| Oripavine (9330) |
II |
| Thebaine (9333) |
II |
| Oxymorphone (9652) |
II |
| Noroxymorphone (9668) |
II |
| Alfentanil (9737) |
II |
| Sufentanil (9740) |
II |
| Carfentanil (9743) |
II |
| Tapentadol (9780) |
II |
| Fentanyl (9801) |
II |
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Noramco, Inc., to manufacture the listed
[[Page 17232]]
basic classes of controlled substances is consistent with the public
interest at this time. DEA has investigated Noramco, Inc., to ensure
that the company's registration is consistent with the public interest.
The investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance
with 21 CFR 1301.33, the above named company is granted registration as
a bulk manufacturer of the basic classes of controlled substances
listed.
Dated: March 12, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2013-06324 Filed 3-19-13; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
